Detalhe da pesquisa
1.
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer.
Eur J Immunol
; 51(4): 956-964, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33506525
2.
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non-small cell lung cancer.
Invest New Drugs
; 40(2): 265-273, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34973117
3.
Role of Circulating Tumor DNA Profiling in Patients with Non-Small Cell Lung Cancer Treated with EGFR Inhibitor.
Oncology
; 100(4): 228-237, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196661
4.
High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
Cancer
; 127(16): 3019-3028, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826761
5.
MDSC subtypes and CD39 expression on CD8+ T cells predict the efficacy of anti-PD-1 immunotherapy in patients with advanced NSCLC.
Eur J Immunol
; 50(11): 1810-1819, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32510574
6.
Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model.
Nanomedicine
; 37: 102415, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34174421
7.
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.
Invest New Drugs
; 38(2): 360-368, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31124056
8.
Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice.
Jpn J Clin Oncol
; 50(5): 594-601, 2020 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32083304
9.
AZD9291 overcomes T790 M-mediated resistance through degradation of EGFR(L858R/T790M) in non-small cell lung cancer cells.
Invest New Drugs
; 34(4): 407-15, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27044261
10.
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
Invest New Drugs
; 33(1): 12-21, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25342139
11.
High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.
J Transl Med
; 12: 299, 2014 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25343854
12.
Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma.
FASEB J
; 27(9): 3487-95, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23704086
13.
Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells.
Amino Acids
; 46(6): 1527-36, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24643363
14.
Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys
; 115(2): 464-475, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35896144
15.
A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21).
J Thorac Oncol
; 18(2): 223-231, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307042
16.
Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non-Small Cell Lung Cancer.
J Thorac Oncol
; 18(9): 1199-1208, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308037
17.
Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.
PLoS One
; 17(10): e0274830, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36201479
18.
Longitudinal monitoring by next-generation sequencing of plasma cell-free DNA in ALK rearranged NSCLC patients treated with ALK tyrosine kinase inhibitors.
Cancer Med
; 11(15): 2944-2956, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35437925
19.
Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1 Therapy.
Int J Radiat Oncol Biol Phys
; 113(2): 415-425, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150786
20.
CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.
Int J Cancer
; 128(6): 1316-26, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20506295